Beone Medicines Ltd Adr (ONC)

Jun 18, 2025

Insider Selling: BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) COO Sells 1,543 Shares of Stock - MarketBeat

Jun 18, 2025

Jun 18, 2025

BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Insider Sells $118,143.90 in Stock - MarketBeat

Jun 18, 2025

Jun 17, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 5.4%Here's What Happened - MarketBeat

Jun 17, 2025

Jun 16, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat

Jun 16, 2025

Jun 13, 2025

Entergy Corp’s Shares Reel: 0.54% Quarterly Revenue Decline Amid 35.88B Market Cap - investchronicle.com

Jun 13, 2025

Jun 13, 2025

BeOne Medicines Ltd ADR (ONC) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 13, 2025

Jun 05, 2025

Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily

Jun 05, 2025

Jun 03, 2025

LLY Stock Quote Price and Forecast - CNN

Jun 03, 2025

Jun 02, 2025

H.C. Wainwright maintains neutral rating on Zymeworks stock - Investing.com India

Jun 02, 2025

May 31, 2025

China approves novel HER2-targeted therapy for BTC By Investing.com - Investing.com South Africa

May 31, 2025

May 30, 2025

Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge By Stocktwits - Investing.com India

May 30, 2025

May 30, 2025

China approves novel HER2-targeted therapy for BTC - Investing.com Australia

May 30, 2025

May 30, 2025

Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer - GlobeNewswire Inc.

May 30, 2025

May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland - Investing.com

May 27, 2025

May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland By Investing.com - Investing.com Nigeria

May 27, 2025

May 26, 2025

Daiwa Raises BEIGENE's TP to HKD180; Brukinsa Sales Growth Outpaces Competitors - AASTOCKS.com

May 26, 2025

May 21, 2025

BeiGene Shareholders Approve Director Elections and Auditors By Investing.com - Investing.com India

May 21, 2025

May 13, 2025

Daiwa Sees Limited Upside for HSI, Prefers HK Stocks w/ Tech Trading Opportunities Like BEIGENE - AASTOCKS.com

May 13, 2025

May 08, 2025

Market Momentum: BeiGene Ltd. ADR (ONC) Registers a -3.93 Decrease, Closing at 232.25 - DWinneX

May 08, 2025

May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates - Investing.com

May 07, 2025

May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates By Investing.com - Investing.com South Africa

May 07, 2025

Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics By Investing.com - Investing.com India

Apr 29, 2025

Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics - Investing.com

Apr 29, 2025

Apr 29, 2025

BeiGene wins US patent dispute over cancer drug By Investing.com - Investing.com India

Apr 29, 2025

Apr 29, 2025

Universal Health Q1 Earnings Beat on Strong Acute Care Admissions - Zacks Investment Research

Apr 29, 2025

Apr 28, 2025

BeiGene reports financial results under PRC GAAP By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

BeiGene reports financial results under PRC GAAP - Investing.com

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 24, 2025

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Apr 24, 2025

Apr 21, 2025

BigBear.ai Holdings Inc (BBAI) gets rating Downgrade from Northland Capital - knoxdaily.com

Apr 21, 2025

Apr 21, 2025

Morgan Stanley analysts upgrades an Equal-weight rating for Urban Edge Properties (UE) - knoxdaily.com

Apr 21, 2025

Apr 21, 2025

RBC Capital Mkts initates BeiGene Ltd. ADR (ONC) rating to an Outperform - knoxdaily.com

Apr 21, 2025

Apr 17, 2025

BGNE Page Not Found - Benzinga

Apr 17, 2025

Apr 16, 2025

Beigene’s Wang Xiaodong sells $10.1m in stock By Investing.com - Investing.com India

Apr 16, 2025

Apr 16, 2025

Beigene’s Wang Xiaodong sells $10.1m in stock - Investing.com

Apr 16, 2025

Apr 16, 2025

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance

Apr 16, 2025

Apr 10, 2025

Permian Resources Corp [PR] Director makes an insider purchase of 250,000 shares worth 3.02 million. - knoxdaily.com

Apr 10, 2025

Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

RBC Capital sets BeiGene stock Outperform with $312 target - Investing.com

Apr 07, 2025

Apr 04, 2025

JMP reiterates BeiGene stock with $348 target despite trial halt - Investing.com India

Apr 04, 2025

Apr 03, 2025

Beigene’s president Wu Xiaobin sells $14.6 million in shares - Investing.com

Apr 03, 2025

Apr 03, 2025

Beigene’s president Wu Xiaobin sells $14.6 million in shares By Investing.com - Investing.com India

Apr 03, 2025

Apr 03, 2025

BeiGene stock slips on trial discontinuation (ONC:NASDAQ) - Seeking Alpha

Apr 03, 2025

Mar 31, 2025

Macquarie Prefers Biotechs Over CDMOs; Top Picks BEIGENE/ AKESO - AASTOCKS.com

Mar 31, 2025

Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Beigene director Wang Xiaodong sells $10.9 million in shares - Investing.com India

Mar 20, 2025

Mar 18, 2025

Beigene’s Wu Xiaobin anticipates $1.06 million from RMB shares sale - Investing.com

Mar 18, 2025